Prevalence of Carriage of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacteria in Preterm Premature Rupture of Membranes : A French Multicenter Cohort Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCentre Hospitalier de Saint-Denis

About this trial

This study looks at how common certain antibiotic-resistant bacteria (called extended-spectrum beta-lactamase-producing Enterobacteriaceae, or E-BLSE) are in pregnant women who experience premature breaking of their water before full term. The goal is to understand how often these bacteria are found, how long they stay, and what factors increase the risk of carrying them. This information will help doctors choose the best antibiotics to protect both the mother and baby from infections during and after pregnancy. The study follows women from the time of their membrane rupture until delivery, collecting samples to track the bacteria over time.

Eligibility criteria

Qualifiers

Pregnant women aged over 18 years

Diagnosed with premature rupture of membranes before term (between 23 weeks + 0 days and 36 weeks + 6 days of gestation)

Managed in one of the participating maternity hospitals

Disqualifiers

No available microbiological sample

Minors or women under legal guardianship (curatorship, tutelage, or judicial protection)

Women who refuse the use of their clinical data for research purposes at admission or within one month after receiving the information document

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed